What is NDC 83098-102?

83098-102 is the product NDC for Dapsone 25 mg (dapsone tablets), Dapsone 25 mg/1 tablet, listed with the FDA by Everest Life Sciences. LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Dapsone 25 mg (Dapsone Tablets).

Everest Life Sciences. LLC, NDC labeler code 83098. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dapsone 25 mg?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dapsone 25 mg NDC 83098-102 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)83098-102Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83098-0102Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
83098-102-01	8309801020183098010201	100 TABLET in 1 BOTTLE (83098-102-01)Marketed from Sep 1, 2024
83098-102-03	8309801020383098010203	30 TABLET in 1 BOTTLE (83098-102-03)Marketed from Sep 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dapsone 25 mg
Generic name (nonproprietary): dapsone tablets
Active ingredients: Dapsone — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Everest Life Sciences. LLCNDC labeler code 83098
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 086841
Marketing start: Sep 1, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Sulfones (Chemical structure)
Identifiers: Product ID 83098-102_2127568d-553c-c142-e063-6394a90a4ef7SPL ID 2127568d-553c-c142-e063-6394a90a4ef7SPL set ID 1d026bb6-05da-e9cf-e063-6394a90a2485RxCUI 197557, 197558UNII 8W5C518302
Pharmacologic class: Sulfone

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N483098010201 followed by a unit qualifier and the quantity

Package 83098-0102-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 2, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Dermatitis herpetiformis: (D.H.) Leprosy: All forms of leprosy except for cases of proven Dapsone resistance.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 83098-102

What is NDC 83098-102?: 83098-102 is the product NDC for Dapsone 25 mg (dapsone tablets), Dapsone 25 mg/1 tablet, listed with the FDA by Everest Life Sciences. LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dapsone 25 mg (Dapsone Tablets).
What is the active ingredient?: Dapsone.
Who is the labeler?: Everest Life Sciences. LLC, NDC labeler code 83098. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dapsone 25 mg?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 086841

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 086841
Product	Strength	Form · route	Labeler	Product NDC
Dapsone	Dapsone 25 mg/1	TabletOral	AvKARE	42291-008
Dapsone	Dapsone 25 mg/1	TabletOral	Westminster Pharmaceuticals, LLC	69367-378
Dapsone	Dapsone 25 mg/1	TabletOral	Westminster Pharmaceuticals, LLC	69367-409
Dapsone	Dapsone 25 mg/1	TabletOral	AvKARE	73190-037
Dapsone	Dapsone 25 mg/1	TabletOral	Proficient Rx LP	82804-988

Dapsone 25 mg (Dapsone tablets) NDC 83098-102